Biogen is a biotechnology company that develops, manufactures, and commercializes therapies for the treatment of neurological and autoimmune diseases. The company's key products include multiple sclerosis treatments such as Avonex, Tysabri, and Plegridy, as well as spinal muscular atrophy treatment Spinraza and Alzheimer's disease treatment Aduhelm. Biogen's innovative therapies have improved the lives of millions of patients worldwide, making it a leader in the healthcare industry.
S&P 500 closing prices, top movers, and sector performance — delivered daily.